Malaria accounts for a substantial amount of perinatal morbidity and mortality among infants born to women living in or traveling to malaria-endemic areas. Infants with congenital or postnatally acquired malaria present with fever, hemolytic anemia, and splenomegaly. Diagnosis can be made by examining thick and thin blood smears. Prompt treatment with oral therapy is associated with good outcomes in most cases, but severe disease may require intravenous therapy or even exchange transfusion to reduce parasite load. Prevention efforts should focus on mosquito avoidance and antimalarial prophylaxis.
KeywordsCongenital malaria Mosquito Parasite Blood smear
- 29.Centers for Disease Control and Prevention. DPDx—laboratory identification of parasitic diseases of public health concern. http://www.cdc.gov/dpdx/contact.html. Accessed 9 Jan 2018.
- 33.Centers for Disease Control and Prevention. Malaria: Malaria treatment (United States). https://www.cdc.gov/malaria/diagnosis_treatment/treatment.html. Accessed 9 Jan 2018.
- 34.World Health Organization. Malaria: intermittent preventive treatment in pregnancy (IPTp). Available at http://www.who.int/malaria/areas/preventive_therapies/pregnancy/en/. Accessed 9 Jan 2018.
- 35.Desai M, Gutman J, L’lanziva A, et al. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomized controlled superiority trial. Lancet. 2015;386:2507–19.CrossRefPubMedPubMedCentralGoogle Scholar